OPINION SURVEY OF THE GENERAL PRACTITIONERS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS

OPINION SURVEY OF THE GENERAL PRACTITIONERS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS

Purpose: Cardiovascular diseases are leading cause of mortality and disability worldwide. Major role in the treatment and prophylaxis of these diseases and their complications have antiplatelet and anticoagulation drugs. Routine practice in the past was an interruption of antiplatelet and anticoagul...

Full description

Bibliographic Details
Main Authors:	Atanaska Dinkova, Dimitar Atanasov, Ludmila G. Vladimirova-Kitova
Format:	Article
Language:	English
Published:	Peytchinski Publishing 2017-11-01
Series:	Journal of IMAB
Subjects:	general practitioners acetylsalicylic acid clopidogrel acenocoumarol tooth extraction
Online Access:	http://www.journal-imab-bg.org/issues-2017/issue4/vol23issue4p1769-1772.html

Similar Items

OPINION SURVEY OF THE CARDIOLOGISTS IN BULGARIA REGARDING THERAPY WITH ACETYLSALICYLIC ACID, CLOPIDOGREL AND ACENOCOUMAROL IN PATIENTS UNDERGOING DENTAL EXTRACTIONS
by: Atanaska Dinkova, et al.
Published: (2017-10-01)

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
by: HU Bachmann
Published: (2004-06-01)

Resistencia al ácido acetil salicílico y al clopidogrel: una entidad clínica emergente Resistance to acetylsalicylic acid and to clopidogrel: an emergent clinical entity
by: José J Lugo, et al.
Published: (2008-08-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)

In Vitro Dissolution Study of Acetylsalicylic Acid and Clopidogrel Bisulfate Solid Dispersions: Validation of the RP-HPLC Method for Simultaneous Analysis
by: Ehlimana Osmanović Omerdić, et al.
Published: (2020-07-01)

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial
by: Carcas Antonio J, et al.
Published: (2012-12-01)

Discontinuation of Oral Antiplatelet Agents before Dental Extraction - Necessity or Myth?
by: Dinkova Atanaska S., et al.
Published: (2017-09-01)

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
by: Angela Roco, et al.
Published: (2020-04-01)

Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece
by: Georgia Kourlaba, et al.
Published: (2021-05-01)

Acenocoumarol Pharmacogenetic Dosing Algorithm versus Usual Care in Patients with Venous Thromboembolism: A Randomised Clinical Trial
by: Hoi Yan Tong, et al.
Published: (2021-06-01)

SAFETY OF TEETH EXTRACTIONS IN PATIENTS ON ACENOCOUMAROL THERAPY
by: Atanaska Dinkova, et al.
Published: (2020-04-01)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
by: Josep Comin Colet, et al.
Published: (2023-07-01)

Successful outcome with outpatient acenocoumarol therapy for echocardiographically visible pulmonary thrombus
by: Karanam Gowrinath, et al.
Published: (2021-01-01)

Better stability of acenocoumarol compared to warfarin treatment in one-year observational, clinical study in patients with nonvalvular atrial fibrillation
by: Lejla Burnazović-Ristić, et al.
Published: (2011-02-01)

Acenocoumarol, an Anticoagulant Drug, Prevents Melanogenesis in B16F10 Melanoma Cells
by: Hyunju Han, et al.
Published: (2023-04-01)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
by: Danilo Menichelli, et al.
Published: (2021-03-01)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
by: Jolanta Sawicka-Powierza, et al.
Published: (2018-05-01)

Acenocoumarol Exerts Anti-Inflammatory Activity via the Suppression of NF-κB and MAPK Pathways in RAW 264.7 Cells
by: Hyun-Ju Han, et al.
Published: (2023-02-01)

Therapy with acetylsalicylic acid does not interfere with oral surgery
by: Dudek Damian, et al.
Published: (2013-08-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

Role of clopidogrel role in secondary prevention of ischemic stroke
by: K. S. Meshkova, et al.
Published: (2014-12-01)

The VKORC1 and CYP2C9 gene variants as pharmacogenetic factors in acenocoumarol therapy in Serbian patients - consideration of hypersensitivity and resistance
by: Rakićević Ljiljana, et al.
Published: (2022-01-01)

RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: D. H. Aynetdinova, et al.
Published: (2015-12-01)

ANTITHROMBIC THERAPY IN THE PRIMARY PREVENTION OF STROKE
by: I. S. Yavelov
Published: (2009-03-01)

FEATURES OF PLATELET HEMOSTASIS IN PATIENTS WITH VARIOUS SENSITIVITY TO ANTIPLATELET THERAPY IN STABLE ANGINA PECTORIS AFTER PLANNED PERCUTANEOUS CORONARY INTERVENTION
by: Pronko T. P., et al.
Published: (2017-12-01)

Acetylsalicylic acid (ASA) as inductor of growth and flowering in tomato
by: Artur Ascanio Almeida Barroso, et al.
Published: (2022-04-01)

Acetylsalicylic acid in the prevention and treatment of ischemic stroke
by: A. V. Fonyakin
Published: (2010-06-01)

ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)

ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID
by: I. N. Bokarev, et al.
Published: (2016-01-01)

ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS
by: A. V. Govorin, et al.
Published: (2015-12-01)

Genotype-phenotype correlations in patients treated with acenocoumarol / Corelaţii genotip-fenotip la pacienţii trataţi cu acenocumarol
by: Militaru Florentina Claudia, et al.
Published: (2014-09-01)

Safety and efficacy of acetylsalicylic acid in the secondary prevention of cardiovascular diseases in combination with comorbid diseases. COVID-19 treatment options
by: O. A. Tsvetkova, et al.
Published: (2021-09-01)

Antitumor effects of cardiovascular drugs
by: I. I. Shaposhnik, et al.
Published: (2020-10-01)

Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study
by: Kerstin Jurk, et al.
Published: (2022-05-01)

Acetylsalicylic acid as the only pharmacological method for the prevention of preeclampsia: A retrospective study
by: Olga M. Kravtsova, et al.
Published: (2023-07-01)

La era de la farmacogenómica: el ejemplo del clopidogrel Farmacogenomics Era: The Clopidogrel Example
by: Allan Ramos-Esquivel, et al.
Published: (2012-03-01)

Intentional acetylsalicylic acid acute intoxication and its clinical management
by: Reza Soleimani, et al.
Published: (2019-09-01)

ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
by: I. V. Zhirov
Published: (2015-12-01)

Preparation and activity of glycosylated acetylsalicylic acid
by: Gangliang Huang, et al.
Published: (2018-02-01)

The effect of doubling the dose of clopidogrel on platelet aggregation in patients with clopidogrel resistance
by: John I. Louca, et al.
Published: (2014-09-01)